Upon binding to CD47 on tumor cells, the cytoplasmic tail of SIRPA becomes tyrosine-phosphorylated, and SHP-1 and SHP-2 phosphatases are recruited and activated, initiating dephosphorylation of downstream substrates [40]. Here, PTPN11 is linked to neoplasm.